未找到相关数据
EVERSUN: A phase II trial of everolimus alternating with sunitinib as first-line therapy for advanced renal cell carcinoma (aRCC) (ANZUP trial 0901)
被引：1
作者：
Davis, Ian D.
Long, Anne
Martin, Andrew
Espinoza, David
Yip, Sonia
Kichenadasse, Ganessan
Thompson, Jennifer F.
Harrison, Michelle L.
Lowenthal, Raymond M.
Pavlakis, Nick
Azad, Arun
Kannourakis, George
Steer, Christopher
Goldstein, David
Shapiro, Jeremy David
Stockler, Martin R.
机构：
[1] Monash Univ, Eastern Hlth Clin Sch, Box Hill, Vic, Australia
[2] Univ Sydney, NHMRC Clin Trials Ctr, Sydney, NSW 2006, Australia
[3] Sydney Catalyst Translat Canc Res Ctr, Sydney, NSW, Australia
[4] Flinders Univ S Australia, Flinders Med Ctr, Adelaide, SA 5001, Australia
[5] Royal Prince Alfred Hosp, Sydney, NSW, Australia
[6] Royal Hobart Hosp, Hobart, Tas, Australia
[7] Univ Sydney, Royal N Shore Hosp, Sydney, NSW 2006, Australia
[8] British Columbia Canc Agcy, Vancouver, BC V5Z 4E6, Canada
[9] Ballarat Oncol & Haematol Serv, Ballarat, Vic, Australia
[10] Border Med Oncol, Wodonga, Australia
[11] Prince Wales Hosp, Sydney, NSW, Australia
[12] Cabrini Hlth, Melbourne, Vic, Australia
关键词：
D O I：
10.1200/jco.2014.32.4_suppl.438
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 [肿瘤学];
摘要：
438
引用
收藏
页数：1
相关论文